The effect of Empagliflozin on the ECG change of STEMI patients who underwent angioplasty ; A double blind randomized clinical trial study
Phase 3
Recruiting
- Conditions
- STEMI patients who underwent angioplasty.ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
- Registration Number
- IRCT20230926059531N1
- Lead Sponsor
- Yazd University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 116
Inclusion Criteria
Acute coronary syndrome(ST Elevation MI )
Exclusion Criteria
type 1 diabetic patients
patients with GFR <30
Diabetic patient under treatment with empagliflozin
Cardiogenic shock due to STEMI
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ECG change of STEMI patients. Timepoint: The beginning of the study and 90th day. Method of measurement: Obtaining an ECG and checking the related changes that are mentioned in the questionnaire.;Left ventricular Ejection Fraction in STEMI patients. Timepoint: The beginning of the study ,40 th day and 90th day. Method of measurement: Obtaining echocardiography and checking the related changes that are mentioned in the questionnaire.;Exercise capacity in STEMI patients. Timepoint: The beginning of the study ,40 th day and 90th day. Method of measurement: The 6- minute walk test.
- Secondary Outcome Measures
Name Time Method